CAR-T Cell Reaserch Chimeric Antigen Receptor (CAR) T cells are an immunotherapy that involves modulating a patients’ own immune cells to recognize and attack their tumors. T cells are removed from a patient and genetically engineered to express receptor’s specific to the subject’s particular cancer. The technology gained wide attention when 6 year old, Emily Whitehead, was cured of ALL by CAR-T cell treatments. It continues to develop and improve as new methods in the generation of CAR-T cells are being discovered. PeproTech and BioGems are proud to offer reagents and ELISA kits to activate, expand, and functionally verify CAR-T cells.
Activation with BioGems CD3 and CD28 Antibodies
AVAILABLE SIZES